Antibiotic Resistance Prevalent Among Staph-Based Eye Infections: Study

Roughly one in three staph infections in the eye are resistant to antibiotics, according to the findings of a new study.

Researchers with the University of Tennessee and Bausch+Lomb found that 75% of eye staph infections which are methicillin resistant are also resistant to three or more other types of antibiotics, making it even more difficult for doctors to treat patients.

In a report published this month in the medical journal JAMA Ophthalmology, researchers outlined the findings of a cross-sectional study involving an ongoing, nationwide, prospective, laboratory-based surveillance trial, the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) study, which includes more than 6,000 ocular isolates.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

The isolates collected from the eye included staphylococcus aureus, coagulase-negative (CoNS) staphylococci, streptococcus pneumonia, pseudomonas aeruginosa, and Haemophilus influenza. The isolates were cultured from patients with eye infections from 2009 and 2018 at centers nationwide.

The data indicates methicillin resistance and multi-drug resistance are common among staph eye infections. According to the findings, more than one-third of staph eye infections were methicillin resistant and half of CoNS infections were methicillin resistant. If bacteria was methicillin resistant it was more likely to be resistant to other antibiotics.

“Antibiotic resistance may be prevalent among staphylococcal isolates, particularly among older patients” researchers wrote. “In this study, a few small differences in antibiotic resistance were observed by geographic region or longitudinally.”

Researchers indicated antibiotic resistance is common in staph eye infections. More than 75% of methicillin resistant staph infections were also resistant to multiple antibiotics, typically three or more classes of antibiotics.

The emergence of bacteria resistant to antibiotics is outpacing the development of new antibiotics to treat the new bacteria, health experts warn. So called “superbugs” and rare antibiotic resistant diseases are being detected more commonly in the U.S. and the world.

The new research also indicates antibiotic resistance profiles were mostly unchanged during the 10 year study period. This is largely because despite the known risks, doctors continue to prescribe antibiotics inappropriately for infections that cannot be treated with antibiotics.

According to the researchers in this latest study, their findings are important because antibiotic resistance in eye infections can complicate treatment.

Antibiotic-resistant infections cause more than 35,000 deaths in the United States each year and sicken nearly 3 million.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges
Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges (Posted 2 days ago)

A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.

Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures
Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures (Posted 2 days ago)

Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted 3 days ago)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.